JOHN FRUTH: Open Payments
NPI 1891197547 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 80 payments from 14 companies in 2025. Trend: 2023 $1,412 · 2024 $1,124 · 2025 $1,544
Food & beverage: $1,503Education: $41
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 22 | $309 |
| AstraZeneca Pharmaceuticals LP | 7 | $281 |
| GlaxoSmithKline, LLC. | 12 | $196 |
| CSL Behring | 9 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $153 |
| Lilly USA, LLC | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 4 | $72 |
| Amgen Inc. | 2 | $54 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $47 |
| PFIZER INC. | 2 | $40 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, Hizentra, EBGLYSS, Rhapsido, TAKHZYRO, CUVITRU.
Industry payments across OH — which companies pay providers there.
